About ClearLight Biotechnologies
ClearLight Biotechnologies is a Healthcare company based in Sunnyvale (United States) founded in 2014 by Karl Deisseroth. Tissue processing and 3D spatial image analysis platforms are provided. ClearLight Biotechnologies has raised $14.92 million across 5 funding rounds. ClearLight Biotechnologies offers products and services including CLARITY Tissue Clearing Kit, Immunostaining Buffer, and Tissue Clearing Kit Refills. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its competitors include PathAI, Viz.ai and Deepcell; 3 of its 3 listed competitors have raised funding.
Company details
ClearLight Biotechnologies was founded in 2014 in Sunnyvale, United States, within the biotechnology sector. A platform for tissue processing and digital spatial image analysis has been developed, allowing 3D examination of preclinical and clinical disease models. Multiple analyses of single samples are supported to assess 3D biomarkers. Services encompass tissue clearing, immunostaining, multiplexed fluorescence imaging, and 3D data interpretation.
- Headquarters Sunnyvale, United States
- Founders Karl Deisseroth
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clearlightbiotechnologies.com
- Social X
- Total Equity Funding$14.92M (USD)
in 5 rounds
- Latest Funding Round$2.77M (USD), Series A
Dec 2018
Products & Services of ClearLight Biotechnologies
ClearLight Biotechnologies offers a comprehensive portfolio of products and services, including CLARITY Tissue Clearing Kit, Immunostaining Buffer, and Tissue Clearing Kit Refills.
Enables lipid clearing for 3D tissue visualization in biomedical research.
Supports immunostaining processes in tissue clearing applications.
Provides refills for ongoing tissue clearing experiments in labs.
Funding Insights of ClearLight Biotechnologies
ClearLight Biotechnologies has successfully raised a total of $14.92M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.77 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.92M
- Total Rounds 5
- Last Round Series A — $2.77M
- First Round $2.58M
(Sep 2015)
All 5 funding rounds of ClearLight Biotechnologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $2.77M | Series A | – | – | – |
| Jan 2017 | $3.5M | Series A | – | – | – |
| Dec 2016 | $3.5M | Series B | – | – | – |
| Oct 2015 | $2.58M | Seed | – | – | – |
| Sep 2015 | $2.58M | Series A | – | – | – |
People of ClearLight Biotechnologies
1 people are tracked at ClearLight Biotechnologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Karl Deisseroth | Founder & Scientific Advisor | Leadership |
Complete people profiles for ClearLight Biotechnologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ClearLight Biotechnologies
3 dated milestones of ClearLight Biotechnologies across 4 years, from founding to its latest funding, stage changes and deals.
- Founded ClearLight Biotechnologies is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Series A, of $2.8M.
Competitors of ClearLight Biotechnologies
ClearLight Biotechnologies has 3 listed competitors in our database, 3 of them funded. They include PathAI, Viz.ai and Deepcell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research |
Detailed competitors of ClearLight Biotechnologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ClearLight Biotechnologies
The website of ClearLight Biotechnologies (clearlightbiotechnologies.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 24.1% vs previous month
Websites whose visitors overlap most with ClearLight Biotechnologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| translucencebio.com | 100% | 2K | #8,545,798 | View details | |
| visikol.com | 85% | 14.9K | #1,805,385 | View details | |
| hellobio.com | 74% | 55.4K | #653,889 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as ClearLight Biotechnologies (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clearlight Biotechnologies
Complete news archive for ClearLight Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClearLight Biotechnologies
ClearLight Biotechnologies was founded in 2014 and raised its 1st funding round 1 year after it was founded.
ClearLight Biotechnologies is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
ClearLight Biotechnologies is a funded company, having raised a total of $14.92M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2.58M, raised on Sep 2015.
ClearLight Biotechnologies was founded in 2014 in Sunnyvale, United States, within the biotechnology sector. A platform for tissue processing and digital spatial image analysis has been developed, allowing 3D examination of preclinical and clinical disease models. Multiple analyses of single samples are supported to assess 3D biomarkers. Services encompass tissue clearing, immunostaining, multiplexed fluorescence imaging, and 3D data interpretation.
ClearLight Biotechnologies offers CLARITY Tissue Clearing Kit, Immunostaining Buffer, and Tissue Clearing Kit Refills.